Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Kannt A, Rajagopal S, Kadnur SV, et al
Comprehensive Support: Achieving sustainable weight loss requires more than just injectionsit requires ongoing support and guidance
Changes to the microbial phyla and genera observed in the 5A-1MQ-treated group switched from WD to LD could have been driven by additive, synergistic, or independent mechanisms relative to those induced by diet switch alone, which could not be determined with the current study design that lacked a group treated with 5A-1MQ and maintained on WD
Energize B-12 Blends Featuring We help you take control of your health and energy with amazing blends of powerful, essential vitamins & minerals
